Back to Research Hub
Becton, Dickinson and Company
BDX
$149.99-1.17 (-0.77%)
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.
StreetsValue research for Becton, Dickinson and Company (BDX)
Members get the full report for Becton, Dickinson and Company: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.